Klaus Lindpaintner, MD, MPH is chief scientific officer and distinguished scientist at InterVenn BioSciences.
Using Novel Biomarkers to Facilitate AI-Driven Glycoproteomics
With the evolution of scalability of peripheral blood protein glycosylation, research has expanded for new biomarkers.